Plans to roll out 35 products by 2016
Mankind Pharma has invested Rs 150 crore in its plant at Paonta Sahib and expects to roll out 35 products by the end of 2016.
With a strategic approach on formulations, the company has been focusing on the manufacturing of nutraceuticals with a growth rate of 35 per cent. Currently, the company’s 80 per cent of niche molecules have been concentrated in the production of nutraceuticals and it has recently introduced 24 products under the segment.